Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 6,256 shares of Arteris stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $11.41, for a total value of $71,380.96. Following the completion of the sale, the chief executive officer now owns 268,520 shares in the company, valued at approximately $3,063,813.20. This trade represents a 2.28 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
K Charles Janac also recently made the following trade(s):
- On Monday, December 30th, K Charles Janac sold 58,212 shares of Arteris stock. The stock was sold at an average price of $10.33, for a total transaction of $601,329.96.
- On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The stock was sold at an average price of $10.42, for a total value of $631,285.28.
- On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total transaction of $141,941.80.
- On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72.
- On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total transaction of $10,656.36.
Arteris Stock Performance
Arteris stock traded up $0.03 on Monday, hitting $12.28. The company's stock had a trading volume of 495,407 shares, compared to its average volume of 869,555. The company has a fifty day moving average price of $9.00 and a 200-day moving average price of $8.08. Arteris, Inc. has a one year low of $4.83 and a one year high of $12.64. The firm has a market cap of $493.37 million, a P/E ratio of -12.79 and a beta of 1.17. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30.
Institutional Trading of Arteris
Several hedge funds have recently modified their holdings of AIP. State Street Corp grew its stake in shares of Arteris by 18.5% during the third quarter. State Street Corp now owns 410,578 shares of the company's stock worth $3,170,000 after purchasing an additional 64,081 shares during the period. Bank of New York Mellon Corp bought a new position in Arteris in the second quarter valued at approximately $580,000. Dynamic Technology Lab Private Ltd acquired a new stake in Arteris in the 3rd quarter valued at about $226,000. Geode Capital Management LLC raised its position in shares of Arteris by 6.6% in the third quarter. Geode Capital Management LLC now owns 597,116 shares of the company's stock valued at $4,610,000 after purchasing an additional 36,908 shares during the period. Finally, US Bancorp DE acquired a new position in Arteris in the 3rd quarter valued at $34,000. 64.36% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Rosenblatt Securities restated a "buy" rating and set a $15.00 target price on shares of Arteris in a report on Wednesday, November 6th.
View Our Latest Report on Arteris
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.